Cargando…
Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a treatment-refractory malignancy with poor prognosis. It is urgent to identify novel and valid biomarkers to predict the progress and prognosis of PDAC. The S100A family have been identified as being involved in cell proliferation, migrati...
Autores principales: | Li, Hong-Bin, Wang, Jian-Li, Jin, Xiao-Dong, Zhao, Lei, Ye, Hui-Li, Kuang, Yan-bei, Ma, Yong, Jiang, Xiang-Yan, Yu, Ze-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447682/ https://www.ncbi.nlm.nih.gov/pubmed/34530774 http://dx.doi.org/10.1186/s12885-021-08769-6 |
Ejemplares similares
-
Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2023) -
Prognostic Value of VEGF in Human Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004) -
Prognostic Values and Clinical Significance of S100 Family Member’s Individualized mRNA Expression in Pancreatic Adenocarcinoma
por: Li, Xiaomin, et al.
Publicado: (2021) -
Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020) -
Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms
por: Liu, Jun-Qi, et al.
Publicado: (2020)